JP2019516729A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516729A5
JP2019516729A5 JP2018560672A JP2018560672A JP2019516729A5 JP 2019516729 A5 JP2019516729 A5 JP 2019516729A5 JP 2018560672 A JP2018560672 A JP 2018560672A JP 2018560672 A JP2018560672 A JP 2018560672A JP 2019516729 A5 JP2019516729 A5 JP 2019516729A5
Authority
JP
Japan
Prior art keywords
compound
general formula
alkyl
halo
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018560672A
Other languages
English (en)
Japanese (ja)
Other versions
JP7034094B2 (ja
JP2019516729A (ja
Filing date
Publication date
Priority claimed from GBGB1608776.9A external-priority patent/GB201608776D0/en
Application filed filed Critical
Publication of JP2019516729A publication Critical patent/JP2019516729A/ja
Publication of JP2019516729A5 publication Critical patent/JP2019516729A5/ja
Application granted granted Critical
Publication of JP7034094B2 publication Critical patent/JP7034094B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018560672A 2016-05-18 2017-05-18 ステロイド4,6-ジエンの6,7-α-エポキシ化のための方法及び中間体 Active JP7034094B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1608776.9 2016-05-18
GBGB1608776.9A GB201608776D0 (en) 2016-05-18 2016-05-18 Methods and compounds
PCT/GB2017/051389 WO2017199036A1 (en) 2016-05-18 2017-05-18 Process and intermediates for the 6,7-alpha-epoxidation of steroid 4,6-dienes

Publications (3)

Publication Number Publication Date
JP2019516729A JP2019516729A (ja) 2019-06-20
JP2019516729A5 true JP2019516729A5 (enExample) 2020-07-02
JP7034094B2 JP7034094B2 (ja) 2022-03-11

Family

ID=56320628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018560672A Active JP7034094B2 (ja) 2016-05-18 2017-05-18 ステロイド4,6-ジエンの6,7-α-エポキシ化のための方法及び中間体

Country Status (14)

Country Link
US (1) US10766921B2 (enExample)
EP (1) EP3458467B1 (enExample)
JP (1) JP7034094B2 (enExample)
KR (1) KR102489565B1 (enExample)
CN (1) CN109415404B (enExample)
AU (1) AU2017265445B2 (enExample)
CA (1) CA3024283C (enExample)
DK (1) DK3458467T3 (enExample)
EA (1) EA038224B1 (enExample)
ES (1) ES2841324T3 (enExample)
GB (1) GB201608776D0 (enExample)
MX (1) MX378594B (enExample)
PT (1) PT3458467T (enExample)
WO (1) WO2017199036A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
CN111560045A (zh) * 2020-06-23 2020-08-21 江苏佳尔科药业集团股份有限公司 一种以ba为原料合成石胆酸的方法
CN114957372B (zh) * 2021-12-07 2023-10-31 湖南醇康医药科技有限公司 10α-甲基-5,7-二烯甾体化合物和地屈孕酮的制备方法
CN114957371B (zh) * 2021-09-08 2023-10-31 湖南醇康医药科技有限公司 地屈孕酮及其中间体化合物的制备方法
GB202416085D0 (en) 2024-10-31 2024-12-18 Nzp Uk Ltd Reduction process

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2624748A (en) 1950-09-09 1953-01-06 Upjohn Co Bisnorchola-4, 6-dien-3-one-22-al
IT1088094B (it) 1976-10-14 1985-06-04 Hoffmann La Roche Derivati del pregnano
US4289872A (en) 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
US5229490A (en) 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
DE3902357A1 (de) 1989-01-27 1990-08-02 Hoechst Ag Verwendung von rheniumorganischen verbindungen zur oxidation von c-c-mehrfachbindungen, darauf basierende oxidationsverfahren und neue rheniumorganische verbindungen
US5166372A (en) 1992-02-07 1992-11-24 Arco Chemical Technology, L.P. Epoxidation process
ATE156158T1 (de) 1992-04-14 1997-08-15 Cornell Res Foundation Inc Makromoleküle auf basis von dendritischen polymeren und verfahren zur herstellung
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5723636A (en) 1996-04-12 1998-03-03 National Starch And Chemical Investment Holding Corporation Methyltrioxorhenium-urea hydrogen peroxide epoxidation of olefins
DK1392714T3 (da) 2001-03-12 2006-01-09 Intercept Pharmaceuticals Inc Steroider som agonister for FXR
US20090062256A1 (en) 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
EP1446438A2 (en) 2001-11-07 2004-08-18 Nektar Therapeutics Al, Corporation Branched polymers and their conjugates
ITMI20030352A1 (it) 2003-02-27 2004-08-28 Chemi Spa Metodo per la sintesi di metiltriossorenio.
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
EP1775304A4 (en) 2004-07-13 2010-04-28 Mitsubishi Chem Corp PROCESS FOR THE PRODUCTION OF STEROIDS
ITMI20050912A1 (it) * 2005-05-19 2006-11-20 Erregierre Spa Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
JP2007210888A (ja) * 2006-01-12 2007-08-23 Mitsubishi Chemicals Corp ステロイド化合物の製造方法
DK2040713T3 (da) 2006-06-27 2014-09-29 Intercept Pharmaceuticals Inc Galdesyrederivater som fxr-ligander til forebyggelsen eller behandlingen af fxr-medierede sygdomme eller tilstande
US8796249B2 (en) 2008-07-30 2014-08-05 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
AU2009316484B2 (en) 2008-11-19 2015-04-16 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
JP2013500986A (ja) 2009-07-29 2013-01-10 ザ・ユニバーシティ・オブ・シカゴ 肝臓x受容体アゴニスト
ES2822375T3 (es) 2012-06-19 2021-04-30 Intercept Pharmaceuticals Inc Preparación de la forma no cristalina del ácido obeticólico
NZ707389A (en) 2012-10-26 2018-08-31 Intercept Pharmaceuticals Inc Process for preparing bile acid derivatives
WO2014085474A1 (en) 2012-11-28 2014-06-05 Intercept Pharmaceuticals, Inc. Treatment of pulmonary disease
US20140206657A1 (en) 2013-01-18 2014-07-24 City Of Hope Bile acid analog tgr5 agonists
WO2015183794A1 (en) 2014-05-27 2015-12-03 City Of Hope Tgr5 agonist complexes for treating diabetes and cancer
KR102526632B1 (ko) 2014-11-19 2023-04-27 엔제트피 유케이 리미티드 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드
EA033427B1 (ru) * 2014-11-19 2019-10-31 Nzp Uk Ltd 6-алкил-7-гидрокси-4-ен-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
JP6698085B2 (ja) 2014-11-19 2020-05-27 エヌゼットピー ユーケー リミテッド ステロイドFXRモジュレーター製造のための中間体としての6α−アルキル−6,7−ジオン−ステロイド
ES2748692T3 (es) 2014-11-19 2020-03-17 Nzp Uk Ltd Esteroides 6.alfa.-alquil-3,7-diona como intermedios para la producción de moduladores FXR de esteroides
WO2016086115A1 (en) 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
CN105348365A (zh) 2014-12-03 2016-02-24 四川百利药业有限责任公司 一种胆酸衍生物及其制备方法、药物组合物和用途
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608777D0 (en) * 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201608779D0 (en) * 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds

Similar Documents

Publication Publication Date Title
Vessally et al. New page to access pyridine derivatives: synthesis from N-propargylamines
Raihan et al. ‘On-water’synthesis of chromeno-isoxazoles mediated by [hydroxy (tosyloxy) iodo] benzene (HTIB)
JP2019516717A5 (enExample)
JP2007530450A5 (enExample)
JP2023544476A5 (enExample)
JP2014518882A5 (enExample)
JP2018529690A5 (enExample)
Diaba et al. Cu (I)-catalyzed atom transfer radical cyclization of trichloroacetamides tethered to electron-deficient,-neutral, and-rich alkenes: synthesis of polyfunctionalized 2-azabicyclo [3.3. 1] nonanes
Pan et al. Construction of highly functional α-amino nitriles via a novel multicomponent tandem organocatalytic reaction: a facile access to α-methylene γ-lactams
JP5499160B2 (ja) 含窒素複素環化合物及びその製造方法
Ziarani et al. The molecular diversity scope of urazole in the synthesis of organic compounds
Chen et al. Palladium catalyzed synthesis of 2-trifluoromethylquinolines through a domino Sonogashira–alkyne carbocyclization process
JP2004511560A5 (enExample)
Dubovtsev Gold-catalyzed O-transfer involving alkynes and nitriles as a straightforward diazo-free route to oxazoles
FI86302C (fi) Foerfarande foer framstaellning av saosom laekemedel anvaendbara asymmetriska esterderivat av 1,4- dihydropyridin-3,5-dikarboxylsyra.
WO2025046090A1 (en) Methods of preparing phosphonamidate compounds
EP1992619A1 (en) Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1H-benzimidazoles and the intermediate compounds used therein
US6716990B2 (en) Process and intermediates for the preparation of imidazopyridines
Gladysz et al. An Unexpected Role of Carbon Disulfide: A New and Efficient Method for the Synthesis of 2‐Substituted Benzimidazoles
Heravi et al. KHSO4 Supported Onto Bentonite, A Versatile Reagent for Aromatization of Hantzsch 1, 4‐Dihydropyridines
Rustin et al. Facile Trifluoromethylation of Arenes and Heterocycles via a Bench Stable Photocaged Trifluoromethylation Reagent
JPWO2017104589A1 (ja) パーフルオロアルキル化化合物の製造方法
Sen et al. An Efficient Practicable Synthesis of 2, 4‐Disubstituted Imidazole Derivatives Using Dual Functions of Deep Eutectic Solvent (DES)
RU99116268A (ru) Способ получения хинолон- и нафтиридонкарбоновых кислот
Basso et al. Multicomponent Reactions under Oxidative Conditions